Publications by authors named "John Sefton"

Claim this Profile
A
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Sewon Kang, Gerald G Krueger, Emil A Tanghetti, Deborah Lew-Kaya, John Sefton

J Am Acad Dermatol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Alan R Shalita, Diane S Berson, Diane M Thiboutot, James J Leyden, Dari Parizadeh, John Sefton

Clin Ther· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
Zhiling Yu, John Sefton, Deborah Lew-Kaya, Patricia Walker, Dale Yu

Clin Pharmacokinet· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
Gerald D Weinstein, John Y M Koo, Gerald G Krueger, Mark G Lebwohl, Nicholas J Lowe, John Sefton

J Am Acad Dermatol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
Tania J Phillips, Alice B Gottlieb, James J Leyden, Nicholas J Lowe, Deborah A Lew-Kaya, John Sefton

Arch Dermatol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis